DGAP-News: FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity

DGAP-News: Apollo Endosurgery, Inc. / Key word(s): Legal Matter FDA Grants De Novo Marketing Authorization to Apollo Endosurgery for Apollo ESG(TM) and Apollo REVISE(TM), New Endoscopic Systems for Patients with Obesity 13.07.2022 / 07:30 The issuer is solely responsible for the content of this ...

Related Keywords

Germany ,Matt Kreps ,Abu Dayyeh ,Jeff Black ,Chas Mckhann ,Apollo Endosurgery ,Centers For Disease ,World Health Organization ,Drug Administration ,Nasdaq ,Distribution Services ,Exchange Commission ,Obesity Action Coalition ,Apollo Endosurgery Inc ,News Service ,Darrow Associates Investor Relations ,Legal Matter ,New Endoscopic Systems ,Offer Effective ,Minimally Invasive Treatment Options ,Body Mass Index ,Endoscopic Suturing System ,Suturing System ,Intragastric Balloon System ,Endoscopic Helix Tacking System ,Digestive Disease Week ,Englj Med ,Health Organization ,Disease Control ,Severe Obesity Forecasts Through ,Chief Financial Officer ,Corporate News ,Regulatory Announcements ,Novo ,Marketing ,Authorization ,Apollo ,Endosurgery ,Sg Tm ,Evise Tm , ,Few ,Endoscopic ,Systems ,Patients ,Obesity ,The ,